Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

AI Briefing

• – Fulcrum Therapeutics grants stock options to new employee.
• – The grant was made under the company's 2022 Inducement Stock Incentive Plan, as amended.
• – The grant was made as an inducement material to the new employee under Nasdaq Listing Rule 5635(c)(4).